Novel Ralstonia species from human infections: improved matrix-assisted laser desorption/ionization time-of-flight mass spectrometry-based identification and analysis of antimicrobial resistance patterns

Stephanie Steyaert,Charlotte Peeters,Anneleen D. Wieme,Astrid Muyldermans,Kristof Vandoorslaer,Theodore Spilker,Ingrid Wybo,Denis Piérard,John J. LiPuma,Peter Vandamme

DOI: https://doi.org/10.1128/spectrum.04021-23

IF: 3.7

2024-04-26

Microbiology Spectrum

Abstract:ABSTRACT A collection of 161 Ralstonia isolates, including 90 isolates from persons with cystic fibrosis, 27 isolates from other human clinical samples, 8 isolates from the hospital environment, 7 isolates from industrial samples, and 19 environmental isolates, was subjected to matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) identification and yielded confident species level identification scores for only 62 (39%) of the isolates, including four that proved misidentified subsequently. Whole-genome sequence analysis of 32 representative isolates for which no confident MALDI-TOF MS species level identification was obtained revealed the presence of seven novel Ralstonia species, including three and four that were isolated from cystic fibrosis or other human clinical samples, respectively, and provided the basis for updating an in-house MALDI-TOF MS database. A reanalysis of all mass spectra with the updated MALDI-TOF MS database increased the percentage of isolates with confident species level identification up to 77%. The antimicrobial susceptibility of 30 isolates mainly representing novel human clinical and environmental Ralstonia species was tested toward 17 antimicrobial agents and demonstrated that the novel Ralstonia species were generally multi-resistant, yet susceptible to trimethoprim/sulfamethoxazole, ciprofloxacin, and tigecycline. An analysis of genomic antimicrobial resistance genes in 32 novel and publicly available genome sequences revealed broadly distributed beta-lactam resistance determinants. IMPORTANCE The present study demonstrated that a commercial matrix-assisted laser desorption/ionization time-of-flight mass spectrometry identification database can be tailored to improve the identification of Ralstonia species. It also revealed the presence of seven novel Ralstonia species, including three and four that were isolated from cystic fibrosis or other human clinical samples, respectively. An analysis of minimum inhibitory concentration values demonstrated that the novel Ralstonia species were generally multi-resistant but susceptible to trimethoprim/sulfamethoxazole, ciprofloxacin, and tigecycline.

microbiology

What problem does this paper attempt to address?

The issues this paper attempts to address include: 1. **Improving the diagnostic accuracy of Ralstonia species in human infections**: - Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) technology, the current commercial database has limitations in identifying certain Ralstonia species, leading to many strains not being accurately identified at the species level. The paper improves the identification accuracy of these strains by updating a self-built MALDI-TOF MS database. 2. **Discovering new Ralstonia species**: - Through whole-genome sequencing analysis of 161 Ralstonia strains, seven new Ralstonia species were discovered, three of which were from cystic fibrosis patients and four from other clinical samples. The discovery of these new species helps to better understand the diversity and distribution of the Ralstonia genus. 3. **Analyzing the antimicrobial resistance patterns of newly discovered species**: - The paper tested the sensitivity of 30 representative strains to 17 antimicrobial agents, finding that the new species generally exhibited multidrug resistance but remained sensitive to trimethoprim-sulfamethoxazole, ciprofloxacin, and tigecycline. This provides important reference information for clinical treatment. 4. **Revealing the distribution of antimicrobial resistance genes**: - Through genomic analysis, the paper revealed the widespread presence of β-lactam resistance genes in the new species, which helps to understand the resistance mechanisms of these species. In summary, this paper aims to improve the diagnostic accuracy of Ralstonia species in human infections through the enhancement of MALDI-TOF MS technology and genomic analysis, and to conduct an in-depth study of the antimicrobial resistance patterns of these species.

Novel Ralstonia species from human infections: improved matrix-assisted laser desorption/ionization time-of-flight mass spectrometry-based identification and analysis of antimicrobial resistance patterns

Isolation and Identification of Ralstonia Mannitolilytica Strains from a Patient with Septicaemia and Analysis of Their Drug Resistance Genes

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for rapid identification of Corynebacterium species of clinical isolates

Rapid Identification of Common Clinical Organism by Matrix-Assisted Laser Desorption/ionization Time Of-Fright Mass Spectrometry

Nosocomial bloodstream infection and the emerging carbapenem-resistant pathogen Ralstonia insidiosa

A Single-Laboratory Performance Evaluation of MALDI-TOF MS in Rapid Identification of Staphylococcus aureus, Cronobacter sakazakii, Vibrio parahaemolyticus, and Some Closely Related Bacterial Species of Public Health Importance

In-depth comparative pathogenome, virulome, and resistome analysis of an extensive drug resistant Ralstonia mannitolilytica strain isolated from blood

Evaluation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Molecular Typing of Acinetobacter baumannii in Comparison with Orthogonal Methods

Functional metagenomics highlights varied infection states with dynamics of pathogens and antibiotic resistance in lower respiratory tract infections

Novel spore-forming species exhibiting intrinsic resistance to third- and fourth-generation cephalosporins and description of Tigheibacillus jepli gen. nov., sp. nov.

Accurate Identification of Common Pathogenic Nocardia Species: Evaluation of a Multilocus Sequence Analysis Platform and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry

Ornithobacterium rhinotracheale: MALDI-TOF MS and Whole Genome Sequencing Confirm That Serotypes K, L and M Deviate from Well-Known Reference Strains and Numerous Field Isolates

MALDI-TOF mass spectrometry from nucleic acid: development and evaluation of a novel platform for identification of mycobacteria and detection of genetic markers of resistance

A Meta-analysis of the known Global Distribution and Host Range of the Ralstonia Species Complex

Identification and specificity validation of unique and antimicrobial resistance genes to trace suspected pathogenic AMR bacteria and to monitor the development of AMR in non-AMR strains in the environment and clinical settings

Identification and distribution of Achromobacter species in cystic fibrosis

Detection of multidrug resistant environmental isolates of acinetobacter and Stenotrophomonas maltophilia: a possible threat for community acquired infections?

MALDI-TOF bacterial subtyping to detect antibiotic resistance

Ralstonia chuxiongensis sp. nov., Ralstonia mojiangensis sp. nov., and Ralstonia soli sp. nov., isolated from tobacco fields, are three novel species in the family Burkholderiaceae

A preliminary study on the homology analysis of clinical Stenotrophomonas maltophilia isolates based on fatty acid profiles.

Use of 16S rRNA Gene for Identification of a Broad Range of Clinically Relevant Bacterial Pathogens